» Authors » Molebogeng X Rangaka

Molebogeng X Rangaka

Explore the profile of Molebogeng X Rangaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 2139
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kilic A, Zhou X, Moon Z, Hamada Y, Duong T, Layton C, et al.
BMC Public Health . 2025 Feb; 25(1):628. PMID: 39953433
Background: Tuberculosis (TB) stigma may be a barrier to engagement in testing and treatment for TB infection (TBI). We systematically reviewed the available evidence on how TB stigma influences engagement...
2.
MacPherson P, Shanaube K, Phiri M, Rickman H, Horton K, Feasey H, et al.
BMC Glob Public Health . 2024 Dec; 2(1):14. PMID: 39690409
No abstract available.
3.
MacPherson P, Shanaube K, Phiri M, Rickman H, Horton K, Feasey H, et al.
BMC Glob Public Health . 2024 Dec; 2(1):9. PMID: 39681899
Community-based active case finding (ACF) for tuberculosis (TB) involves an offer of screening to populations at risk of TB, oftentimes with additional health promotion, community engagement and health service strengthening....
4.
Bashir S, Ali S, Yerlikaya S, Gaeddert M, Gosce L, Rangaka M, et al.
PLOS Glob Public Health . 2024 Nov; 4(11):e0003638. PMID: 39536008
The economic value of new skin-based tests and blood-based interferon-γ release assays (IGRAs) for tuberculosis (TB) infection is not yet well-established. This study evaluates the cost and cost-effectiveness in two...
5.
Gosce L, Allel K, Hamada Y, Surkova E, Kontsevaya I, Wang T, et al.
PLOS Glob Public Health . 2024 Oct; 4(10):e0003655. PMID: 39401209
The Purified Protein Derivative tuberculin skin tests (TST) and blood-based Mycobacterium tuberculosis (M.tb) specific interferon-gamma release assays (IGRA) are the currently used tests for identifying individuals with TB infection for...
6.
Hamada Y, Quartagno M, Malik F, Ntshamane K, Tisler A, Gaikwad S, et al.
Trop Med Int Health . 2024 Jul; 29(9):768-780. PMID: 39073229
Objective: To investigate the prevalence of non-communicable diseases among household contacts of people with tuberculosis. Methods: We conducted a systematic review and individual participant data meta-analysis. We searched Medline, Embase...
7.
Churchyard G, Houben R, Fielding K, Fiore-Gartland A, Esmail H, Grant A, et al.
Lancet Microbe . 2024 Jul; 5(10):100895. PMID: 38964359
Tuberculosis is a leading cause of death from an infectious agent globally. Infectious subclinical tuberculosis accounts for almost half of all tuberculosis cases in national tuberculosis prevalence surveys, and possibly...
8.
Kilic A, Clarke A, Moon Z, Hamada Y, Chan A, Rahman A, et al.
Dialogues Health . 2024 Mar; 4:100162. PMID: 38516222
Background: COVID-19 disrupted the TB prevention programme in the UK, especially for TB infection (TBI) care. We explore whether experience of the COVID-19 pandemic impacted on patients' perceptions of TBI...
9.
Hamada Y, Quartagno M, Law I, Malik F, Bonsu F, Adetifa I, et al.
PLOS Glob Public Health . 2024 Feb; 4(2):e0002596. PMID: 38422092
Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB requiring shared prevention and care strategies. We conducted an individual participant...
10.
White R, Fiore-Gartland A, Hanekom W, Vekemans J, Garcia-Basteiro A, Churchyard G, et al.
Lancet Respir Med . 2024 Jan; 12(3):e7-e8. PMID: 38272048
No abstract available.